Justin Smith
Stock Analyst at Bernstein
(4.28)
# 1,380
Out of 4,587 analysts
175
Total ratings
65%
Success rate
10.5%
Average return
Main Sectors:
Stocks Rated by Justin Smith
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: SAN Sanofi | Maintained: Buy | €107.00 | €72.29 | +48.01% | 3 | Jul 30, 2026 | |
| LON: AZN AstraZeneca PLC | Maintained: Buy | 18,900p → 20,200p | 12,758p | +58.33% | 34 | Jul 29, 2026 | |
| LON: GSK GSK plc | Maintained: Buy | 2,630p → 2,825p | 1,956p | +44.43% | 24 | Jul 28, 2026 | |
| LON: 0QW0 argenx SE | Maintained: Buy | €877.00 → €986.00 | €748.40 | +31.75% | 13 | Jul 28, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Buy | CHF 395.00 → CHF 434.50 | CHF 351.40 | +23.65% | 26 | Jul 27, 2026 | |
| SWX: LONN Lonza Group AG | Maintained: Buy | n/a | $576.00 | - | 9 | Jul 24, 2026 | |
| SWX: NOVN Novartis AG | Rated: Hold | CHF 125.00 → CHF 133.00 | CHF 126.74 | +4.94% | 2 | Jul 22, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Sell | kr 175.00 | kr 335.80 | -47.89% | 2 | May 6, 2026 | |
| NVS Novartis AG | Initiated Coverage: Hold | n/a | $157.34 | - | 1 | Mar 19, 2026 | |
| ETR: MRK Merck KGaA | Initiated Coverage: Hold | €112.00 | €143.00 | -21.68% | 1 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | kr 1,015 → kr 1,400 | kr 1,892 | -25.98% | 9 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $28.26 | - | 1 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $24.64 | - | 8 | Aug 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €10.50 → €2.90 | €0.94 | n/a | 3 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €22.00 → €21.50 | €10.53 | n/a | 2 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $85 → $51 | $64.49 | n/a | 10 | Mar 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $104 | $128.59 | n/a | 4 | Mar 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €45.80 → €71.00 | €44.27 | n/a | 7 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €69.00 → €70.00 | €44.80 | n/a | 6 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $54.99 | n/a | 2 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $172 → $140 | $257.10 | n/a | 4 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $52.43 | n/a | 1 | Sep 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $12.80 | n/a | 1 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $25.47 | n/a | 1 | Feb 24, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $78 | $1,176.33 | n/a | 1 | Apr 7, 2016 |
Sanofi
Jul 30, 2026
Maintained: Buy
Price Target: €107.00
Current: €72.29
Upside: +48.01%
AstraZeneca PLC
Jul 29, 2026
Maintained: Buy
Price Target: 18,900p → 20,200p
Current: 12,758p
Upside: +58.33%
GSK plc
Jul 28, 2026
Maintained: Buy
Price Target: 2,630p → 2,825p
Current: 1,956p
Upside: +44.43%
argenx SE
Jul 28, 2026
Maintained: Buy
Price Target: €877.00 → €986.00
Current: €748.40
Upside: +31.75%
Roche Holding AG
Jul 27, 2026
Maintained: Buy
Price Target: CHF 395.00 → CHF 434.50
Current: CHF 351.40
Upside: +23.65%
Lonza Group AG
Jul 24, 2026
Maintained: Buy
Price Target: n/a
Current: $576.00
Upside: -
Novartis AG
Jul 22, 2026
Rated: Hold
Price Target: CHF 125.00 → CHF 133.00
Current: CHF 126.74
Upside: +4.94%
Novo Nordisk A/S
May 6, 2026
Maintained: Sell
Price Target: kr 175.00
Current: kr 335.80
Upside: -47.89%
Novartis AG
Mar 19, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $157.34
Upside: -
Merck KGaA
Mar 18, 2026
Initiated Coverage: Hold
Price Target: €112.00
Current: €143.00
Upside: -21.68%
Feb 23, 2026
Maintained: Sell
Price Target: kr 1,015 → kr 1,400
Current: kr 1,892
Upside: -25.98%
Sep 8, 2025
Reiterated: Sell
Price Target: n/a
Current: $28.26
Upside: -
Aug 17, 2025
Maintained: Hold
Price Target: n/a
Current: $24.64
Upside: -
Mar 31, 2025
Downgraded: Hold
Price Target: €10.50 → €2.90
Current: €0.94
Upside: n/a
Dec 10, 2024
Maintained: Buy
Price Target: €22.00 → €21.50
Current: €10.53
Upside: n/a
Mar 11, 2024
Downgraded: Hold
Price Target: $85 → $51
Current: $64.49
Upside: n/a
Mar 11, 2024
Downgraded: Sell
Price Target: $104
Current: $128.59
Upside: n/a
Nov 17, 2023
Upgraded: Buy
Price Target: €45.80 → €71.00
Current: €44.27
Upside: n/a
Nov 17, 2023
Maintained: Buy
Price Target: €69.00 → €70.00
Current: €44.80
Upside: n/a
Feb 27, 2023
Upgraded: Buy
Price Target: n/a
Current: $54.99
Upside: n/a
Nov 8, 2022
Downgraded: Hold
Price Target: $172 → $140
Current: $257.10
Upside: n/a
Sep 3, 2019
Upgraded: Buy
Price Target: n/a
Current: $52.43
Upside: n/a
Nov 12, 2018
Maintained: Buy
Price Target: n/a
Current: $12.80
Upside: n/a
Feb 24, 2017
Downgraded: Hold
Price Target: n/a
Current: $25.47
Upside: n/a
Apr 7, 2016
Initiated Coverage: Hold
Price Target: $78
Current: $1,176.33
Upside: n/a